Qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition
Qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition
Qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition
Budesonide, prolonged release tablets, 9 mg product-specific bioequivalence guidance
Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 16, Status: Authorised
Contractor SOP/MLM - WIN/MLM
EVVet3 EVWeb Production – Release notes
First EMA-Animal Health Europe annual bilateral meeting , Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 13:30 (CEST) to 1 July 2024, 15:00 (CEST)
Agenda of the CHMP meeting 24-27 June 2024
QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised, mutual recognition and decentralised procedures - Species pictograms
Summary of opinion: Stronghold Plus, 19/06/2024 Positive
Summary of opinion: Rabitec, 19/06/2024 Positive